Construction and characterization of a hybrid mouse mammary tumor virus/murine leukemia virus-based retroviral vector

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1699-1703

  Saller, Robert M ^a,b   Öztürk, Feride ^a,c   Salmons, Brian ^b   Günzburg, Walter H ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Bavarian Nordic GmbH   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; GENE DUPLICATION; GENE EXPRESSION; HORMONE RESPONSIVE ELEMENT; LONG TERMINAL REPEAT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; VIRUS DNA CELL DNA INTERACTION;

EID: 2642670314     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1699-1703.1998     Document Type: Article

References (26)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Cannon, P. M., N. Kim, S. M. Kingsman, and A. J. Kingsman. 1996. Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. J. Virol. 70:8234-8240.
3. Ferrari, G., G. Salvatori, C. Rossi, G. Cossu, and F. Mavilio. 1995. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum. Gene Ther. 6:733-742.
4. Goff, S. P. 1992. Genetics of retroviral integration. Annu. Rev. Genet. 26: 527-544.
5. Günzburg, W. H., and B. Salmons. 1992. Factors controlling the expression of mouse mammary tumour virus. Biochem. J. 283:625-632.
6. Günzburg, W. H., and B. Salmons. 1986. Mouse mammary tumour virus mediated transfer and expression of neomycin resistance to infected cultured cells. Virology 155:236-248.
7. Hantzopoulos, P. A., B. A. Sullenger, G. Ungers, and E. Gilboa. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86:3519-3523.
8. Hornsby, P. J., and B. Salmons. 1994. Oncogene-expressing cell lines, p. 2.1-2.5. In A. Doyle, J. B. Griffiths, and D. G. Newell (ed.), Cell and tissue culture: laboratory procedures, module 26D. John Wiley & Sons. Ltd., Chichester, United Kingdom.
9. Jaggi, R., B. Salmons, D. Muellener, and B. Groner. 1986. The v-mos and H-ras oncogene expression represses glucocorticoid hormone dependent transcription from the mouse mammary tumor virus LTR. EMBO J. 5:2609-2616.
10. Luciw, P. A., and N. J. Leung. 1992. Mechanisms of retrovirus replication, p. 159-298. In J. A. Levy (ed.), The retroviridae, vol. 1. Plenum Press, New York, N.Y.
11. Miksicek, R., A. Heber, W. Schmid, U. Danesch, G. Posseckert, M. Beato, and G. Schutz. 1986. Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell 46:283-290.
12. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
13. Mink, S., E. Härtig, P. Jennewein, W. Doppler, and A. C. B. Cato. 1992. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/ NFI and a novel transcription factor, mammary cell-activating factor. Mol. Cell. Biol. 12:4906-4918.
14. Mok, E., T. V. Golovkina, and S. R. Ross. 1992. A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice. J. Virol. 66:7529-7532.
15. Morris, D. W., H. D. Bradshaw, Jr., H. T. Billy, R. J. Munn, and R. D. Cardiff. 1989. Isolation of a pathogenic clone of mouse mammary tumor virus. J. Virol. 63:148-158.
16. Overhauser, J., and H. Fan. 1985. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat. J. Virol. 54: 133-144.
17. Price, J., D. Turner, and C. Cepko. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84:156-160.
18. Robinson, D., J. F. Elliott, and L. J. Chang. 1995. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Gene Ther. 2:269-278.
19. Ross, S. R., C.-L. L. Hsu, Y. Choi, E. Mok, and J. P. Dudley. 1990. Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol. Cell. Biol. 10:5822-5829.
20. Saller, R. M. 1994. Design von locus-und gewebespezifischen retroviralen Vektoren für eine in vivo Gentherapie. Doctoral thesis. Ludwig-Maximilian University, Munich, Germany.
21. Salmons, B., B. Groner, C. M. Calberg-Bacq, and H. Ponta. 1985. Production of mouse mammary tumor virus upon transfection of a recombinant proviral DNA into cultured cells. Virology 144:101-114.
22. Salmons, B., S. Moritz-Legrand, I. Garcha, and W. H. Günzburg. 1989. Construction and characterization of a packaging cell line for MMTV-based retroviral vectors. Biochem. Biophys. Res. Commun. 159:1191-1198.
23. Shackleford, G. M., and H. E. Varmus. 1988. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85:9655-9659.
24. Sparmann, G., W. Walther, W. H. Günzburg, W. Uckert, and B. Salmons. 1994. Conditional expression of human TNF-α: a system for inducible cytotoxicity. Int. J. Cancer 59:103-107.
25. Vile, R. G., R. M. Diaz, N. Miller, S. Mitchell, A. Tuszyanski, and S. J. Russell. 1995. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer promoter. Virology 214:307-313.
26. Yu, S. F., T. von Ruden, P. W. Kantoff, C. Garber, M. Seiberg, U. Ruther, W. F. Anderson, E. F. Wagner, and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83:3194-3198.